TAFFA N TMUSNIWIN TUSNANIN

Guidelines for detection and management of hyperbilirubinemia in term and late preterm newborns (≥35 weeks gestational age)

Canadian Paediatric SocietyTaseḍṛit n warrac2025Asuffeɣ unṣib

Agzul n yisemli ASEM

Official Canadian Paediatric Society document (2025) on “Guidelines for detection and management of hyperbilirubinemia in term and late preterm newborns (≥35 weeks gestational age)”. Hyperbilirubinemia is a common condition and is usually benign in term and late preterm newborns. Developing a standardized approach for all newborns to prevent, identify, and manage those with clinically significant hyperbilirubinemia will minimize the potential risks of long-term neurological sequelae from acute bilirubin encephalopathy and kernicterus. This statement provides recommendations on universal screening.

Agzul-a ad k-yefk tallalt deg unadi ɣef uttaft. I wellihen klinik, ẓer yal tikkelt lqem unṣib amiran akked uzemz n uleqqem-is.

Isemli unṣib